Paper9820175
Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent.
Ando Y and 6 others. Br J Cancer, 1998. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent. Papers, record 9820175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9820175
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cytochrome P-450 Enzyme Inhibitors | Major topic |
| Enzyme Inhibitors | Major topic |
| Organoplatinum Compounds | Major topic |
| Cytochrome P-450 Enzyme System | |
| Humans | |
| Hydroxylation | |
| Kinetics | |
| Microsomes, Liver | |
| Paclitaxel | |
| Testosterone |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7028434 | Inhibitors of Cytochrome P-450s and their mechanism of action. | Drug Metab Rev | 1981 | https://conductscience.org/library/papers/7028434 | PubMed |
| 2 | 9137529 | Combination chemotherapy involving orally administered etoposide and JM-216 in murine tumor models. | Cancer Chemother Pharmacol | 1997 | https://conductscience.org/library/papers/9137529 | PubMed |
| 3 | 3997827 | Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. | J Biol Chem | 1985 | https://conductscience.org/library/papers/3997827 | PubMed |
| 4 | 3729972 | The nature of microsomal monooxygenase inhibition by cimetidine. | Biochem Pharmacol | 1986 | https://conductscience.org/library/papers/3729972 | PubMed |
| 5 | 3259858 | Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme. | Arch Biochem Biophys | 1988 | https://conductscience.org/library/papers/3259858 | PubMed |
| 6 | 3263862 | Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics. | Biochem Pharmacol | 1988 | https://conductscience.org/library/papers/3263862 | PubMed |
| 7 | 2572912 | Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients. | Lancet | 1989 | https://conductscience.org/library/papers/2572912 | PubMed |
| 8 | 1648142 | Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. | J Natl Cancer Inst | 1991 | https://conductscience.org/library/papers/1648142 | PubMed |
| 9 | 1784230 | Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. | Methods Enzymol | 1991 | https://conductscience.org/library/papers/1784230 | PubMed |
| 10 | 1381906 | Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. | Arch Biochem Biophys | 1992 | https://conductscience.org/library/papers/1381906 | PubMed |
| 11 | 8388318 | Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. | Cancer Res | 1993 | https://conductscience.org/library/papers/8388318 | PubMed |
| 12 | 8242617 | Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. | Cancer Res | 1993 | https://conductscience.org/library/papers/8242617 | PubMed |
| 13 | 7903909 | Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. | Cancer Res | 1994 | https://conductscience.org/library/papers/7903909 | PubMed |
| 14 | 8114683 | O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. | Mol Pharmacol | 1994 | https://conductscience.org/library/papers/8114683 | PubMed |
| 15 | 8137461 | Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8137461 | PubMed |
| 16 | 7913410 | Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. | Cancer Res | 1994 | https://conductscience.org/library/papers/7913410 | PubMed |
| 17 | 7923194 | Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8. | Cancer Res | 1994 | https://conductscience.org/library/papers/7923194 | PubMed |
| 18 | 7575674 | Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. | Biochem Pharmacol | 1995 | https://conductscience.org/library/papers/7575674 | PubMed |
| 19 | 7494563 | Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. | N Engl J Med | 1996 | https://conductscience.org/library/papers/7494563 | PubMed |
| 20 | 8640817 | Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans. | Cancer Res | 1996 | https://conductscience.org/library/papers/8640817 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819598 | Icariin: from preclinical promise to clinical reality-a critical evidence-based assessment. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42819598 | PubMed |
| 25556988 | Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors. | Pediatr Blood Cancer | 2015 | https://conductscience.org/library/papers/25556988 | PubMed |
| 19888874 | Satraplatin: leading the new generation of oral platinum agents. | Expert Opin Investig Drugs | 2009 | https://conductscience.org/library/papers/19888874 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP1A1 | 1543 | PubTator's text mining | https://conductscience.org/library/genes/1543 | NCBI Gene |
| CYP1A2 | 1544 | PubTator's text mining | https://conductscience.org/library/genes/1544 | NCBI Gene |
| CYP2A6 | 1548 | PubTator's text mining | https://conductscience.org/library/genes/1548 | NCBI Gene |
| CYP2C8 | 1558 | PubTator's text mining | https://conductscience.org/library/genes/1558 | NCBI Gene |
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 | NCBI Gene |
| CYP2E1 | 1571 | PubTator's text mining | https://conductscience.org/library/genes/1571 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9820175
GET https://conductscience.org/api/papers/v1/9820175/references?page=2